Clinical Trials

Showing trials with last updates posted in 2020.

NCT04470440 | COMPLETED
134 participants

Thyroid Dysfunction and Nivolumab Reponse in NSCLC

Study Type:
OBSERVATIONAL
Last Updated:
2020-07-14
Start Date:
2019-10-22
Completion:
2019-11-05
Conditions
  • Non Small Cell Lung Cancer Metastatic
  • Treatment Adverse Effect
  • Thyroid Dysfunction
  • Immune Checkpoint Inhibitor
  • Prognosis
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page